肥厚型心肌病患者的心房颤动：消融需谨慎。 - Suppr

Suppr

超能文献

Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Caveat Ablator.

作者信息

Marine Joseph E, Vasquez Nestor

机构信息

Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

出版信息

JACC Adv. 2024 Mar 15;3(5):100900. doi: 10.1016/j.jacadv.2024.100900. eCollection 2024 May.

DOI:10.1016/j.jacadv.2024.100900

PMID:38939643

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11198182/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c445/11198182/a57653be57e6/ga1.jpg

相似文献

Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Caveat Ablator.肥厚型心肌病患者的心房颤动：消融需谨慎。

JACC Adv. 2024 Mar 15;3(5):100900. doi: 10.1016/j.jacadv.2024.100900. eCollection 2024 May.

Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy.肥厚型梗阻性心肌病患者行心肌切除术同期行房颤消融术。

J Thorac Cardiovasc Surg. 2018 Apr;155(4):1536-1542.e2. doi: 10.1016/j.jtcvs.2017.08.063. Epub 2017 Sep 1.

Does ablation of atrial fibrillation at the time of septal myectomy improve survival of patients with obstructive hypertrophic cardiomyopathy?在室间隔肌切除术时进行房颤消融是否能提高梗阻性肥厚型心肌病患者的生存率？

J Thorac Cardiovasc Surg. 2021 Mar;161(3):997-1006.e3. doi: 10.1016/j.jtcvs.2020.08.066. Epub 2020 Aug 25.

Mesh ablator vs. cryoballoon pulmonary vein ablation of symptomatic paroxysmal atrial fibrillation: results of the MACPAF study.网状热凝球与冷冻球囊肺静脉消融治疗症状性阵发性心房颤动的比较：MACPAF 研究结果。

Europace. 2012 Oct;14(10):1441-9. doi: 10.1093/europace/eus084. Epub 2012 Apr 20.

Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: long-term outcomes and mechanisms of arrhythmia recurrence.肥厚型心肌病中心房颤动的导管消融：长期结果和心律失常复发的机制。

Circ Arrhythm Electrophysiol. 2013 Dec;6(6):1089-94. doi: 10.1161/CIRCEP.113.000339. Epub 2013 Oct 10.

Catheter ablation of atrial fibrillation in patients with and without hypertrophic cardiomyopathy: systematic review and meta-analysis.心房颤动患者伴或不伴肥厚型心肌病的导管消融治疗：系统评价和荟萃分析。

Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad256.

Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者非药物治疗心房颤动的结果。

Heart Rhythm. 2015 Jul;12(7):1438-47. doi: 10.1016/j.hrthm.2015.03.042. Epub 2015 Mar 23.

Outcomes of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.

Am J Cardiol. 2023 Nov 15;207:1-3. doi: 10.1016/j.amjcard.2023.08.156. Epub 2023 Sep 15.

Acute myocardial infarction occurring after hypertrophic obstructive cardiomyopathy with paroxysmal atrial fibrillation: a case report.肥厚型梗阻性心肌病伴阵发性心房颤动后发生的急性心肌梗死：1 例报告。

J Int Med Res. 2022 Oct;50(10):3000605221133702. doi: 10.1177/03000605221133702.

Impact of percutaneous transluminal septal myocardial ablation on refractory paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy.

Angiology. 2008 Jun-Jul;59(3):329-34. doi: 10.1177/0003319707305406. Epub 2008 Apr 2.

本文引用的文献

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南：心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。

J Am Coll Cardiol. 2024 Jan 2;83(1):109-279. doi: 10.1016/j.jacc.2023.08.017. Epub 2023 Nov 30.

Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad256.

Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: A proportional meta-analysis and systematic review of single-arm studies.肥厚型心肌病患者心房颤动的导管消融：单臂研究的比例Meta分析与系统评价

Heart Rhythm O2. 2023 Jan 13;4(4):258-267. doi: 10.1016/j.hroo.2023.01.002. eCollection 2023 Apr.

Left atrial contractile strain predicts recurrence of atrial tachyarrhythmia after catheter ablation.左心房收缩应变可预测导管消融后房性心动过速的复发。

Int J Cardiol. 2022 Jul 1;358:51-57. doi: 10.1016/j.ijcard.2022.04.056. Epub 2022 Apr 22.

Cryoballoon Ablation as Initial Treatment for Atrial Fibrillation: JACC State-of-the-Art Review.冷冻球囊消融作为心房颤动的初始治疗：JACC 最新观点综述。

J Am Coll Cardiol. 2021 Aug 31;78(9):914-930. doi: 10.1016/j.jacc.2021.06.038.

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020年美国心脏协会/美国心脏病学会肥厚型心肌病患者诊断和治疗指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告

J Am Coll Cardiol. 2020 Dec 22;76(25):e159-e240. doi: 10.1016/j.jacc.2020.08.045. Epub 2020 Nov 20.

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.心房颤动患者的早期节律控制治疗。

N Engl J Med. 2020 Oct 1;383(14):1305-1316. doi: 10.1056/NEJMoa2019422. Epub 2020 Aug 29.

Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association.生活方式和危险因素的改变以减少心房颤动：美国心脏协会的科学声明。

Circulation. 2020 Apr 21;141(16):e750-e772. doi: 10.1161/CIR.0000000000000748. Epub 2020 Mar 9.

Low Left Atrial Strain Is Associated With Adverse Outcomes in Hypertrophic Cardiomyopathy Patients.左房应变率低值与肥厚型心肌病患者不良结局相关。

J Am Soc Echocardiogr. 2019 May;32(5):593-603.e1. doi: 10.1016/j.echo.2019.01.007. Epub 2019 Mar 20.

Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.肥厚型心肌病中心房颤动的临床特征和后果。

Circulation. 2017 Dec 19;136(25):2420-2436. doi: 10.1161/CIRCULATIONAHA.117.029267. Epub 2017 Sep 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验